Evidence map›Paper›PMID 21611724›Full record

Trial reportPsychopharmacology2011

Human cognitive flexibility depends on dopamine D2 receptor signaling.

Mieke van Holstein, Esther Aarts, Marieke E van der Schaaf, Dirk E M Geurts, Robbert J Verkes, Barbara Franke, Martine R van Schouwenburg, Roshan Cools

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  4. Trial
  5. Trial
  6. Dopaminergic influences on emotional decision making in euthymic bipolar patients.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Tips and tricks in tremor treatment.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  13. Role of dopamine agonists in Parkinson's disease therapy.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Review
  14. Article
  15. Review
  16. Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mieke van HolsteinDonders Institute for Brain, Cognition and Behaviour (RU/DI-BCB), Radboud University Nijmegen, Kapittelweg 29, 6521 EN Nijmegen, the Netherlands. m.vanholstein@donders.ru.nl
Esther Aarts
Marieke E van der Schaaf
Dirk E M Geurts
Robbert J Verkes
Barbara Franke
Martine R van Schouwenburg
Roshan Cools
Radboud University Medical Center · NLRadboud University Nijmegen · NLUniversity of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleAccumulating evidence indicates that the cognitive effects of dopamine depend on the subtype of dopamine receptor that is activated. In particular, recent work with animals as well as current theorizing has suggested that cognitive flexibility depends on dopamine D2 receptor signaling. However, there is no evidence for similar mechanisms in humans.

objectivesWe aim to demonstrate that optimal dopamine D2 receptor signaling is critical for human cognitive flexibility.

methodsTo this end, a pharmacological pretreatment design was employed. This enabled us to investigate whether effects of the dopamine receptor agonist bromocriptine on task-set switching were abolished by pretreatment with the D2 receptor antagonist sulpiride. To account for individual (genetic) differences in baseline levels of dopamine, we made use of a common variable number of tandem repeat (VNTR) polymorphism in the 3'-untranslated region of the dopamine transporter gene, DAT1.

resultsBromocriptine improved cognitive flexibility relative to placebo, but only in subjects with genetically determined low levels of dopamine (n = 27). This beneficial effect of bromocriptine on cognitive flexibility was blocked by pretreatment with the selective dopamine D2 receptor antagonist sulpiride (n = 14).

conclusionsThese results provide strong evidence in favor of the hypothesis that human cognitive flexibility implicates dopamine D2 receptor signaling.

Indexed as

AdolescentAdultBromocriptineCognitionCross-Over StudiesDopamine AgonistsDopamine AntagonistsDopamine Plasma Membrane Transport ProteinsDouble-Blind MethodFemaleHumansMalePolymorphism, GeneticReceptors, Dopamine D2Signal TransductionSulpirideBromocriptineDopamine AgonistsDopamine AntagonistsDopamine Plasma Membrane Transport ProteinsReceptors, Dopamine D2SLC6A3 protein, humanSulpiride

Identifiers

PMID21611724
PMCPMC3210362
OpenAlexW1978036977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.